Recently, we showed that the blockade of AM signaling selectively targets unstable tumor neovessels through rapid disengagement of the VE-cadherin/β-catenin complex, destabilization of the cytoskeleton organization of endothelial cells, and subsequent apoptosis-mediated cell death [46]. Here, CDH5 is linked to neoplasm.